NASDAQ: HALO · Health Care / Biotechnology: Biological Products (No Diagnostic Substances)

Halozyme Therapeutics Inc.

How Halozyme Therapeutics Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$14.9B

Price

$131.18

P/E

36.2

EPS (TTM)

$3.63

1-year return

101.0%

Dividend yield

0.0%

52-week range

$68.97–$131.18

Compared with

• Biotechnology: Biological Products (No Diagnostic Substances) industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources